首页 | 本学科首页   官方微博 | 高级检索  
     


Real‐world effectiveness and safety of paritaprevir/ritonavir,ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
Authors:Chen‐Hua Liu  Chun‐Jen Liu  Tung‐Hung Su  Hung‐Chih Yang  Chun‐Ming Hong  Tai‐Chung Tseng  Pei‐Jer Chen  Ding‐Shinn Chen  Jia‐Horng Kao
Affiliation:1. Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;2. Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan;3. Department of Internal Medicine, National Taiwan University Hospital, Yun‐Lin Branch, Douliou, Taiwan;4. Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan;5. Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan;6. Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan;7. National Taiwan University Hospital, Jinshan Branch, New Taipei City, Taiwan;8. Genomics Research Center, Academia Sinica, Taipei, Taiwan
Abstract:
Keywords:Asian  direct acting antiviral agent  hepatitis C virus  sustained virologic response
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号